Commitment to Action

Reduce Maternal Mortality with Magnesium Sulfate

Commitment by

EngenderHealth

In 2008, EngenderHealth committed to reduce maternal mortality resulting from pre-eclampsia and eclampsia (one of the leading causes of maternal deaths) by increasing the use of magnesium sulfate, an effective and inexpensive, but underutilized treatment. The primary intervention is the creation and dissemination of e-learning tools for health care providers in India, Nigeria, and Mexico
At last reporting in 2011, EngenderHealth and the University of Oxford have developed a web-based interactive teaching tool (e-learning module) in both English and Spanish, which is now available for free to health professionals worldwide, who can train in the evidence-based management of pre-eclampsia and eclampsia. EngenderHealth and the University of Oxford completed an extensive review of the most up-to-date evidence on the management of pre-eclampsia and eclampsia worldwide, which informed the module's content; developed the module; and field tested the module among 20 health professionals from Mexico, Nigeria and India. Next, formal trainings for 120 health professionals using the module will be held across these three countries.

Share

Tabs

Overview
Summary

Commitment

Reduce Maternal Mortality with Magnesium Sulfate

Launched

2008

Est. Duration

1 year

Estimated Total Value

$2,000,000

Region

Asia, Latin America & Caribbean, Africa

Countries

INDIA, MEXICO, NIGERIA, PAKISTAN

Commitment by

EngenderHealth

Partner(s) of the Commitment Maker(s)

University of Oxford, MacArthur Foundation